Filing Details

Accession Number:
0001179110-15-012678
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-26 17:51:32
Reporting Period:
2015-08-21
Filing Date:
2015-08-26
Accepted Time:
2015-08-26 17:51:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882095 Gilead Sciences Inc GILD Biological Products, (No Disgnostic Substances) (2836) 943047598
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190578 C John Martin Gilead Sciences, Inc.
333 Lakeside Drive
Foster City CA 94404
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-08-21 133,213 $0.00 4,081,279 No 5 G Direct
Common Stock Disposition 2015-08-24 133,213 $0.00 3,948,066 No 5 G Direct
Common Stock Acquisiton 2015-08-24 133,213 $0.00 133,213 No 4 A Indirect by Trust
Common Stock Disposition 2015-08-25 59,800 $104.33 73,413 No 4 S Indirect by Trust
Common Stock Disposition 2015-08-25 56,613 $105.68 16,800 No 4 S Indirect by Trust
Common Stock Disposition 2015-08-25 16,800 $106.45 0 No 4 S Indirect by Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 5 G Direct
No 4 A Indirect by Trust
No 4 S Indirect by Trust
No 4 S Indirect by Trust
No 4 S Indirect by Trust
Footnotes
  1. Shares gifted to charitable trust
  2. Sale prices reported for the transactions reported here range from $104.17 to $105.13. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
  3. Sale prices reported for the transactions reported here range from $105.20 to $106.19. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
  4. Sale prices reported for the transactions reported here range from $106.23 to $106.73. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.